Malawi’s private sector is struggling to expand against a backdrop of economic headwinds and regulatory bottlenecks. GDP per capita has been falling for three years, inflation is close to 30 percent, ...

The college, which is part of the Mormon church’s educational system, was approved to offer three-year degrees two and a half years ago. Now, all 10 of its majors will be available in a reduced-credit ...

In tandem with the price volatility, the implied volatility (IV) for both metals has already reached extreme levels in the option market. For instance, the screenshot below was taken from ...

The top college football teams in the country are built in the trenches. What good is an elite quarterback or running back without a top offensive line to block for them? It all starts upfront. That's ...

Homeowners in parts of western Washington whose properties were damaged or destroyed by this month’s historic flooding may have the option to sell their homes to local governments through voluntary ...

Perpetuals-focused Ethereum-based Layer 2 decentralized exchange (DEX) Lighter has announced the debut of its native cryptocurrency, the Lighter Infrastructure Token (LIT), to align traders, builders, ...

– Weekly Oral Helicase-Primase Inhibitor Programs' Early Data Potentially Supportive of First New Treatment for Recurrent Genital Herpes in 25 Years – FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.

(RTTNews) - Gilead Sciences (GILD) and Assembly Biosciences (ASMB) announced Gilead has exercised its combined option to exclusively license Assembly Bio's herpes simplex virus helicase-primase ...

FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus ...